Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sin Nombre virus full-length M segment-based DNA vaccines

Sin Nombre virus full-length M segment-based DNA vaccines

US Patent 10443073 · Granted Oct 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for the production of human polyclonal antibodies2025
Sin Nombre virus full-length M segment-based DNA vaccines2021
Systems and methods for the production of human polyclonal antibodies2021
Therapeutic compositions for neutralizing type I interferons, and methods of use2020
Therapeutic compositions for neutralizing type I interferons, and methods of use2018
Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-lengt2016
Puumala virus full-length M segment-based DNA vaccines2014
DNA immunogenic composition comprising a full-length modified poxvirus L1R gene 2013
Puumala virus full-length M segment-based DNA vaccines2012
Protein vaccines against poxviruses2010
Extraneous DNA sequence that facilitates hantavirus gene expression2007
Prophylactic and therapeutic monoclonal antibodies2003